English
Arabic
Chinese (Simplified)
Dutch
Esperanto
French
German
Greek
Italian
Japanese
Korean
Portuguese
Russian
Spanish
UrduThe John and Daria Barry Foundation will expand clinical and research programs on eye disease
Tag: Eye Disease
New Grants for Big Data Research to Improve Vision Care
The American Academy of Ophthalmology (AAO) and Research to Prevent Blindness (RPB) today announced the 2024 recipients of the RPB / AAO Award for IRIS Registry Research.
New Grants for Big Data Research to Improve Vision Care
The American Academy of Ophthalmology and Research to Prevent Blindness announce recipients of this year’s RPB / AAO Award for IRIS Registry Research.
Repurposed drug may help stabilize vision in rare disease
Washington University School of Medicine in St. Louis led a clinical trial that tests the safety and efficacy of an FDA-approved drug in stabilizing vision in patients with RVCL-S, a rare genetic disease that affects tiny blood vessels in the body.
Tracy M. Valorie joins Glaucoma Research Foundation Board of Directors
Glaucoma Research Foundation, the nation’s most experienced foundation dedicated solely to glaucoma research and education, has elected Tracy M. Valorie, BS, MBA to its Board of Directors.
Artificial Intelligence Matches or Outperforms Human Specialists in Retina and Glaucoma Management, Mount Sinai Study Finds
Research shows this tool can strongly support clinicians for patient care
Wake Forest University School of Medicine Launches Translational Eye and Vision Research Center
Wake Forest University School of Medicine has launched a new Translational Eye and Vision Research Center, located inside Biotech Place, in Innovation Quarter in Winston-Salem, North Carolina. Leaders envision the center serving as a visionary hub that will redefine the landscape of eye and vision research.
Older people may have glaucoma without realizing it
It can be hard to know that you have glaucoma. In a study carried out at the University of Gothenburg, almost five percent of 70-year-olds were found to have glaucoma, and half of those diagnosed were unaware that they had the disease.
UC Irvine researchers discover a nanobody which may lead to treatment for Retinitis Pigmentosa
A special antibody derived from llamas —called a nanobody — can stop the misfolding and the activation of Rhodopsin, a molecule whose mutations can lead to blindness.
Research to Prevent Blindness and Association of University Professors of Ophthalmology Announce 2024 Recipient of RPB David F. Weeks Award for Outstanding Vision Research
Patricia Ann D’Amore, PhD, MBA, has been selected as the 2024 RPB David F. Weeks Award for Outstanding Vision Research (Weeks Award). Dr. D’Amore will receive her award and deliver a presentation during the AUPO 2024 Annual Meeting in Austin, Texas in February.
Mount Sinai Launches Center for Ophthalmic Artificial Intelligence and Human Health
The Icahn School of Medicine at Mount Sinai has launched the Center for Ophthalmic Artificial Intelligence and Human Health, the first of its kind in New York and one of the first in the United States.
AI Used to Advance Drug Delivery System for Glaucoma and Other Chronic Diseases
Wilmer Eye Institute, Johns Hopkins Medicine researchers say they have used artificial intelligence models and machine-learning algorithms to successfully predict which components of amino acids that make up therapeutic proteins are most likely to safely deliver therapeutic drugs to animal eye cells.
Mount Sinai Researchers First to Identify That Two Separate Eye Diseases May Contribute to Common Blinding Eye Condition
Two separate eye diseases may contribute to age-related macular degeneration (AMD), a leading cause of blindness in the United States, according to a new study from New York Eye and Ear Infirmary of Mount Sinai.
Research to Prevent Blindness Marks $400 Million in Funding to Advance Eye Disease Research
Research to Prevent Blindness announces a new round of awardees who are generating critical knowledge around a host of sight-threatening conditions. With this latest round of funding, RPB has provided more than $400 million in research funding.
High-Tech Imaging Offers New Way to Detect Signs of Early Glaucoma
Mount Sinai study shows flavoprotein fluorescence could serve as new biomarker
Black Patients Found Six Times More Likely to Have Advanced Vision Loss After Glaucoma Diagnosis Than White Patients
Black patients have a dramatically higher risk of advanced vision loss after a new diagnosis of primary open angle glaucoma (POAG) when compared to white patients, according to a new study from New York Eye and Ear Infirmary of Mount Sinai (NYEE).
Blinding Eye Disease Is Strongly Associated With Heart Disease and Stroke
Patients with a specific form of age-related macular degeneration (AMD), a leading cause of blindness in the United States, are at significant risk for cardiovascular disease and stroke, according to new research from New York Eye and Ear Infirmary of Mount Sinai.
High Caffeine Consumption may be Associated with Increased Risk of Blinding Eye Disease
Frequent caffeine intake could more than triple risk of glaucoma for those genetically predisposed to higher eye pressure
Cold sores: Discovery reveals how stress, illness and even sunburn trigger flareups
The finding could lead to new ways to prevent cold sores and herpes-related eye disease from reoccurring, the researchers report.
Low-Carbohydrate Diet May Be Associated With Lower Risk of Blinding Eye Disease
Following a long-term diet that’s low in carbohydrates and high in fat and protein from vegetables may lower the risk of the most common subtype of glaucoma
Research to Prevent Blindness Expands Career Development Award
Research to Prevent Blindness announces exciting changes to its flagship grant, the RPB Career Development Award, by increasing both the amount of funding and the number of awards funded.
Artificial Intelligence Algorithm Can Rapidly Detect Severity of Common Blinding Eye Disease
A new artificial intelligence (AI) algorithm developed by researchers at New York Eye and Ear Infirmary of Mount Sinai (NYEE) can rapidly and accurately detect age-related macular degeneration (AMD), a leading cause of vision loss in the United States.
First FDA-approved drug for thyroid eye disease effective regardless of age, gender
Teprotumumab, the first FDA-approved medicine for thyroid eye disease, provides significant improvement in eye bulging, regardless of patient gender, age or smoking status, according to a study accepted for presentation at ENDO 2020, the Endocrine Society’s annual meeting, and publication in a special supplemental section of the Journal of the Endocrine Society.
Scientists successfully test new way to deliver gene therapy
Researchers at Case Western Reserve University, funded in part through a Gund-Harrington Scholar grant at University Hospitals in Cleveland, have used used chemically modified lipids—instead of the viruses most commonly used as carriers— to safely deliver gene therapy to fight a rare, but irreversible, genetic eye disorder known as Stargardt disease.
Potential Way to Halt Blinding Macular Degeneration Identified
It would be the first treatment for “dry” age-related macular degeneration and could significantly improve treatment for wet AMD.
‘Ojos’ study to examine eye disease in Latino communities
With $9.7 million in funding from the National Eye Institute, researchers at the University of Illinois at Chicago will study the impact of chronic eye disease among Latinos.
Telescope technology used to take first accurate images of glaucoma-related eye structure
Researchers at the IU School of Optometry have used adaptive optics technology to create the first undistorted microscopic images of the eye’s trabecular meshwork, which could help improve treatment for glaucoma.